| WO2008051889
| |
| | be flexible and capable of being attached
|
| Pellets containing an analgesic uniformly
| |
| | to a patient without interfering with the
|
| dispersed in a lipid carrier such as
| |
| | patient's daily routine. The phototherapy
|
| cholesterol mixed with fatty acid esters,
| |
| | bandage may easily conform to the curves
|
| can be used to provide long term pain
| |
| | of a patient and may come in a variety of
|
| relief. 5 mg cholesterol-tryglyceride-
| |
| | exterior shapes and sizes.
|
| buprenorphine pellets released the
| |
| | WO2008021404
|
| majority of drug in 24-48 hours after
| |
| | A composition providing cobalamine,
|
| implant and provide clinically significant
| |
| | cobalamine subtype or cobalamine analog as
|
| plasma levels of analgesia in mice for 3-9
| |
| | an effective agent for topical or
|
| days. Blood levels of analgesia peak at
| |
| | transdermal administration to alleviate
|
| day-1 and are substantially complete by
| |
| | pain associated with a generalized or
|
| day-5 depending on the level of
| |
| | focal peripheral neuropathic condition,
|
| buprenorphine. These results demonstrate
| |
| | such as carpal tunnel syndrome. Pain
|
| that post surgical implants provide
| |
| | relief compositions for use in
|
| clinically significant levels of analgesia
| |
| | complementary therapy are also provided.
|
| in the 24-48 hour period following surgery
| |
| | US2007276457
|
| and thus obviate the time consuming,
| |
| | An infrared heating device and therapy for
|
| expensive, and high-risk need to inject
| |
| | lower back pain includes a belt fastenable
|
| mice post surgery. The pellets are safe
| |
| | around a user so that the belt is
|
| and easy to use. Placed in the surgical
| |
| | overlaying at least a portion of a lumbar
|
| wound at the end of surgery, they provide
| |
| | region of the user. An infrared emitting
|
| 2-3 days of analgesia and obviate the need
| |
| | element is adjustably positionable between
|
| for subsequent handling of the animal for
| |
| | the belt and at a selected area of the
|
| pain therapy. The implants have no
| |
| | user's lumbar region where a user desires
|
| detectable effect on mouse behavior,
| |
| | pain relief therapy. A portable power
|
| hematology, or liver chemistry. The
| |
| | supply is attachable to the belt and
|
| unexpected release kinetics of the 5 mg
| |
| | electrically connectable to the infrared
|
| pellet provides an ideal implant for post
| |
| | emitting element so that the user can
|
| surgical analgesia. These implants solve a
| |
| | receive infrared therapy at specific
|
| significant problem facing scientists who
| |
| | selected areas of the lower back while
|
| use rodents in research and abide by
| |
| | moving, standing, sitting, reclining or
|
| international of animal welfare.
| |
| | sleeping.
|
| US2008058689
| |
| | US2007255187
|
| A phototherapy bandage capable of
| |
| | A device for providing therapy to a user
|
| providing radiation to a localized area of
| |
| | including vibration and temperature
|
| a patient for accelerating would healing
| |
| | modulation. The device provides mobile
|
| and pain relief, photodynamic therapy, and
| |
| | temperature modulation capabilities,
|
| for aesthetic applications. The
| |
| | mobile vibration capabilities, or a
|
| phototherapy bandage may include a
| |
| | combination of the two. The device
|
| flexible light source that is continuous
| |
| | provides advantages to a person or animal
|
| across the bandage for providing a
| |
| | including the ability to utilize the
|
| selected light, such as a visible light, a
| |
| | device in a hands-free manner. The device
|
| near-infrared light, or other light,
| |
| | may also provide, under certain
|
| having substantially similar intensity
| |
| | circumstances, pain relief or healing
|
| across the bandage. The bandage may also
| |
| | therapy to a person or animal.
|
